An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Adverse reactions
- Sponsors Roche
- 01 Dec 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Actual initiation date changed from Aug 2012 to Sep 2012, as reported by ClinicalTrials.gov.